T. Rowe Price Health Sciences Fund
T. Rowe Price Health Sciences Fund (PRHSX) Stock Overview
Explore T. Rowe Price Health Sciences Fund’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
12.6B
P/E Ratio
N/A
EPS (TTM)
$2.64
ROE
N/A
PRHSX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of T. Rowe Price Health Sciences Fund (PRHSX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 58.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $89.55.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 12.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies. It is non-diversified.
T. Rowe Price Health Sciences Fund, Inc., MD
1995